RE:RE:RE:Financing with new investorThere is no short answer for that. Everything seems to be lining up great for them though.
Small number of shares tightly held. (Including my own)
2nd Phase 3 trial results to be released soon.
Safty results of 2 phase 3 trials show it is safe
efficacy in all trials to date shows that it protects hearing substantially.
Many companies looking for drugs rugs to fill the pipeline.
Potential for a or a priority voucher worth over 100 million.
Substantial amount of historic cost cost to offset future income.
From there here it's just math. Future cash flows discounted back to today. You can easily get 20 to 30 dollars USD.
I expect they they will sell in the next 12 months for something in that range.
Just my opinion though.